145 related articles for article (PubMed ID: 17188867)
1. 1,5-Benzodioxepin derivatives as a novel class of muscarinic M3 receptor antagonists.
Sonda S; Katayama K; Fujio M; Sakashita H; Inaba K; Asano K; Akira T
Bioorg Med Chem Lett; 2007 Feb; 17(4):925-31. PubMed ID: 17188867
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and optimization of novel and selective muscarinic M(3) receptor antagonists.
Kumar N; Kaur K; Aeron S; Dharmarajan S; Silamkoti AD; Mehta A; Gupta S; Chugh A; Gupta JB; Salman M; Palle VP; Cliffe IA
Bioorg Med Chem Lett; 2007 Sep; 17(18):5256-60. PubMed ID: 17629699
[TBL] [Abstract][Full Text] [Related]
3. Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice.
Ito Y; Oyunzul L; Yoshida A; Fujino T; Noguchi Y; Yuyama H; Ohtake A; Suzuki M; Sasamata M; Matsui M; Yamada S
Eur J Pharmacol; 2009 Aug; 615(1-3):201-6. PubMed ID: 19446545
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.
Naito R; Yonetoku Y; Okamoto Y; Toyoshima A; Ikeda K; Takeuchi M
J Med Chem; 2005 Oct; 48(21):6597-606. PubMed ID: 16220976
[TBL] [Abstract][Full Text] [Related]
5. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
[TBL] [Abstract][Full Text] [Related]
6. In vivo demonstration of M3 muscarinic receptor subtype selectivity of darifenacin in mice.
Yamada S; Maruyama S; Takagi Y; Uchida S; Oki T
Life Sci; 2006 Dec; 80(2):127-32. PubMed ID: 16996089
[TBL] [Abstract][Full Text] [Related]
7. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
[TBL] [Abstract][Full Text] [Related]
8. Discovery of diaryl imidazolidin-2-one derivatives, a novel class of muscarinic M3 selective antagonists (Part 1).
Peretto I; Forlani R; Fossati C; Giardina GA; Giardini A; Guala M; La Porta E; Petrillo P; Radaelli S; Radice L; Raveglia LF; Santoro E; Scudellaro R; Scarpitta F; Bigogno C; Misiano P; Dondio GM; Rizzi A; Armani E; Amari G; Civelli M; Villetti G; Patacchini R; Bergamaschi M; Delcanale M; Salcedo C; Fernández AG; Imbimbo BP
J Med Chem; 2007 Apr; 50(7):1571-83. PubMed ID: 17352462
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of DA-8010, a novel muscarinic receptor antagonist selective for urinary bladder over salivary gland.
Lee MJ; Moon JH; Lee HK; Cho CH; Choi SH; Im WB
Eur J Pharmacol; 2019 Jan; 843():240-250. PubMed ID: 30502343
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological properties of TD-6301, a novel bladder selective muscarinic receptor antagonist.
McNamara A; Pulido-Rios MT; Sweazey S; Obedencio GP; Thibodeaux H; Renner T; Armstrong SR; Steinfeld T; Hughes AD; Wilson RD; Jasper JR; Mammen M; Hegde SS
Eur J Pharmacol; 2009 Mar; 605(1-3):145-52. PubMed ID: 19168050
[TBL] [Abstract][Full Text] [Related]
11. Selective muscarinic antagonists. II. Synthesis and antimuscarinic properties of biphenylylcarbamate derivatives.
Naito R; Takeuchi M; Morihira K; Hayakawa M; Ikeda K; Shibanuma T; Isomura Y
Chem Pharm Bull (Tokyo); 1998 Aug; 46(8):1286-94. PubMed ID: 9734316
[TBL] [Abstract][Full Text] [Related]
12. First dual M3 antagonists-PDE4 inhibitors: synthesis and SAR of 4,6-diaminopyrimidine derivatives.
Provins L; Christophe B; Danhaive P; Dulieu J; Durieu V; Gillard M; Lebon F; Lengelé S; Quéré L; van Keulen B
Bioorg Med Chem Lett; 2006 Apr; 16(7):1834-9. PubMed ID: 16439121
[TBL] [Abstract][Full Text] [Related]
13. Antispasmodic action of propinox on the isolated human gallbladder: possible mechanism of action.
Baistrocchi RL; Orti E; de los Santos AR; Di Girolamo G; Marti ML; Pico JC
Acta Physiol Pharmacol Ther Latinoam; 1999; 49(3):161-9. PubMed ID: 10797855
[TBL] [Abstract][Full Text] [Related]
14. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U
J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246
[TBL] [Abstract][Full Text] [Related]
15. The effect of absolute configuration on activity, subtype selectivity (M3/M2) of 3α-acyloxy-6β-acetoxyltropane derivatives as muscarinic M3 receptor antagonists.
Wang ZP; Liu HZ; Zhu L; Hu YM; Cui YY; Niu YY; Lu Y; Chen HZ
Bioorg Med Chem; 2013 Mar; 21(5):1234-9. PubMed ID: 23375092
[TBL] [Abstract][Full Text] [Related]
16. Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.
Gupta S; Singh RK; Nanda K; Chatterjee M; Tiwari A; Sundaram S; Gupta D; Chugh A; Dastidar S; Ray A
J Recept Signal Transduct Res; 2009; 29(2):100-6. PubMed ID: 19288301
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.
Sagara Y; Sagara T; Uchiyama M; Otsuki S; Kimura T; Fujikawa T; Noguchi K; Ohtake N
J Med Chem; 2006 Sep; 49(19):5653-63. PubMed ID: 16970392
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice.
Oki T; Sato S; Miyata K; Yamada S
Br J Pharmacol; 2005 May; 145(2):219-27. PubMed ID: 15753946
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.
Naruganahalli KS; Sinha S; Hegde LG; Meru AV; Chugh A; Kumar N; Gupta JB; Ray A
Eur J Pharmacol; 2007 Oct; 572(2-3):207-12. PubMed ID: 17610864
[TBL] [Abstract][Full Text] [Related]
20. Alkyne-quinuclidine derivatives as potent and selective muscarinic antagonists for the treatment of COPD.
Starck JP; Provins L; Christophe B; Gillard M; Jadot S; Lo Brutto P; Quéré L; Talaga P; Guyaux M
Bioorg Med Chem Lett; 2008 Apr; 18(8):2675-8. PubMed ID: 18359633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
